Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy
EYENAnnounces private placement
June 17, 2025Investment
Read more →Eyenovia (EYEN) Stock Explodes Following Amended Loan Agreement Terms: What's Going On?
EYENEyenovia amended its loan with Avenue Capital, changing stock conversion option terms. New rules cap lender ownership and protect rights during major corporate fundamental transactions.
June 5, 2025
Read more →Eyenovia (EYEN) Shares Explode On Betaliq Merger Progress, Strong Q1 Financials
EYENEyenovia shares surged on merger progress with Betaliq and improved Q1 financials. They extended merger talks and reported a narrower net loss due to restructuring.
May 20, 2025
Read more →Eyenovia Provides Updates On Potential Merger With Betaliq And Development Of The Optejet User Filled Device; Says Co's Continue To Negotiate A Binding Merger Agreement, Have Agreed To Extend The Binding Exclusivity Period Set Forth In The Letter Of Inten
EYENMay 19, 2025
Read more →Eyenovia Q1 EPS $(1.59) Beats $(9.60) Estimate, Sales $14.72K
EYENMay 19, 2025
Read more →Eyenovia Advances User-Filled Optejet Toward Market with Strong Safety and Dosing Results
EYENApril 10, 2025
Read more →HC Wainwright & Co. Reiterates Neutral on Eyenovia, Maintains $2 Price Target
EYENMarch 21, 2025
Read more →Market-Moving News for March 20th
EYENMarch 20, 2025
Read more →Eyenovia Enters Non-binding Letter Of Intent Contemplating Potential Reverse Merger Transaction With Betaliq; Proposed Transaction Assumes Value For Betaliq Of $77M And Eyenovia Of $15M
EYENMarch 20, 2025
Read more →Eyenovia Shares Surge After Regaining Nasdaq Compliance: What's Going On?
EYENEyenovia, Inc. (NASDAQ: EYEN) shares are trading higher Wednesday after the company announced it had regained compliance with Nasdaq listing requirements.
February 26, 2025
Read more →Eyenovia Regains Compliance With Nasdaq Continued Listing Requirements
EYENFebruary 26, 2025
Read more →Eyenovia Allows Full Debt Conversion to Common Shares at $1.68 Starting April 2025, Defers Payments Until September 2025
EYENFebruary 24, 2025
Read more →Eyenovia Announces Leading Proxy Advisory Firms, ISS And Glass Lewis, Recommend Eyenovia Stockholders Vote FOR Proposed Reverse Stock Split Between 1-For-40 And 1-For-80 At Upcoming Special Meeting of Stockholders
EYENJanuary 15, 2025
Read more →Eyenovia shares are trading lower after Ladenburg Thalmann downgraded the stock from Buy to Neutral. Also, HC Wainwright & Co. downgraded the stock from Buy to Neutral and lowered its price target from $12 to $2.
EYENNovember 18, 2024
Read more →HC Wainwright & Co. Downgrades Eyenovia to Neutral, Lowers Price Target to $2
EYENNovember 18, 2024
Read more →Ladenburg Thalmann Downgrades Eyenovia to Neutral
EYENNovember 18, 2024
Read more →William Blair Downgrades Eyenovia to Market Perform
EYENNovember 15, 2024
Read more →Brookline Capital Downgrades Eyenovia to Hold
EYENNovember 15, 2024
Read more →Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline
EYENEyenovia's Phase 3 CHAPERONE study fails to meet its primary endpoint, prompting a review of strategic alternatives, including potential mergers or asset sales.
November 15, 2024
Read more →Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times
EYENNovember 15, 2024
Read more →Eyenovia Says Considering Variety Of Steps To Maximize Value To All Stakeholders, To Reduce Expenses And To Evaluate Its Strategic Options
EYENNovember 15, 2024
Read more →Eyenovia Says Disappointed That DRC Determined That Chaperone Study Does Not Appear To Be Meeting Its Primary Efficacy Endpoint; To Discontinue Study, Review Full Data Set, And Evaluate Next Steps For The Program
EYENNovember 15, 2024
Read more →Trading Halt: Halted at 6:55:00 a.m. ET - Trading Halt: Halt News Pending
EYENNovember 15, 2024
Read more →HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target
EYENMay 16, 2024
Read more →